Jaime Pérez-Oteyza

6PUBLICATIONS
39CO-AUTHORS
Haematological tumoursGene expression (incl. microarray and other genome-wide approaches)Immunogenetics (incl. genetic immunology)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 16, 2025
Tafasitamab plus lenalidomide as salvage therapy in diffuse large B-cell lymphoma: real-world experience from GELTAMO.

Antonio Gutierrez, Izaskun Zeberio, Francisco Javier Peñalver

|Mar 11, 2025
Genetic subtyping by Whole Exome Sequencing across Diffuse Large B Cell Lymphoma and Plasmablastic Lymphoma.

Aitana Avendaño Pomares, Laura Rodríguez Merino, Sonia González

|Jan 23, 2024
COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant.

Joaquín Martínez-López, Javier de la Cruz, Rodrigo Gil-Manso

|Jun 02, 2021
SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line Treatment.

Mariana Bastos Oreiro, Reyes Martín, Pilar Gomez

|Apr 25, 2020
Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-Cell Lymphoma.

Leo I Gordon, Jason B Kaplan, Rakesh Popat

Pageof 1